Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray

Figure 1

Analysis of ICAM1 expression based on TCGA, Provisional (a, b) and GEO datasets (c, d, e). (a) Gene alterations in ICAM1 in serous ovarian carcinoma. (b) ICAM1 mRNA levels were consistent with gene amplification. Functional plotting of the corresponding mRNA levels based on the TCGA database. ((c), (d), (e) correspond to GSE105437, GSE18520, GSE10971, respectively) ICAM1 mRNA levels were higher in high-grade serous ovarian carcinoma samples than in normal samples.

(a)

(b)

(c)

(d)

(e)